P C Clahsen

1.1k total citations
23 papers, 882 citations indexed

About

P C Clahsen is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, P C Clahsen has authored 23 papers receiving a total of 882 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Cancer Research, 13 papers in Oncology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in P C Clahsen's work include Breast Cancer Treatment Studies (14 papers), Cancer Treatment and Pharmacology (7 papers) and Cancer Cells and Metastasis (3 papers). P C Clahsen is often cited by papers focused on Breast Cancer Treatment Studies (14 papers), Cancer Treatment and Pharmacology (7 papers) and Cancer Cells and Metastasis (3 papers). P C Clahsen collaborates with scholars based in Netherlands, Belgium and France. P C Clahsen's co-authors include C J van de Velde, Marc J. van de Vijver, Christian Duval, A.M. Mandard, C. Pallud, A Delobelle-Deroïde, Lambertus van den Broek, Jean‐Pierre Julien, J.-L. Floiras and F Mignolet and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and British Journal of Cancer.

In The Last Decade

P C Clahsen

22 papers receiving 859 citations

Peers

P C Clahsen
Matías E. Valsecchi United States
N.J. Bundred United Kingdom
M. Stierer Austria
Matías E. Valsecchi United States
P C Clahsen
Citations per year, relative to P C Clahsen P C Clahsen (= 1×) peers Matías E. Valsecchi

Countries citing papers authored by P C Clahsen

Since Specialization
Citations

This map shows the geographic impact of P C Clahsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P C Clahsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P C Clahsen more than expected).

Fields of papers citing papers by P C Clahsen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P C Clahsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P C Clahsen. The network helps show where P C Clahsen may publish in the future.

Co-authorship network of co-authors of P C Clahsen

This figure shows the co-authorship network connecting the top 25 collaborators of P C Clahsen. A scholar is included among the top collaborators of P C Clahsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P C Clahsen. P C Clahsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Clahsen, P C, et al.. (2024). Severe case of pustular psoriasis during pregnancy. BMJ Case Reports. 17(3). e258198–e258198.
2.
Ruiter, Godard C. W. de, P C Clahsen, & J. Wolter Oosterhuis. (2021). Suprainguinal Re-Resection of the Lateral Femoral Cutaneous Nerve in Persistence or Recurrence of Meralgia Paresthetica After Previous Transection: Results of a Case Series. World Neurosurgery. 155. e830–e835. 2 indexed citations
3.
Cohen, Daniëlle, Dina Ruano, Anne‐Marie Cleton-Jansen, et al.. (2020). Optimizing Mutation and Fusion Detection in NSCLC by Sequential DNA and RNA Sequencing. Journal of Thoracic Oncology. 15(6). 1000–1014. 77 indexed citations
4.
Balkenhol, Maschenka, David Tellez, Willem Vreuls, et al.. (2019). Deep learning assisted mitotic counting for breast cancer. Laboratory Investigation. 99(11). 1596–1606. 73 indexed citations
5.
Balkenhol, Maschenka, Peter Bult, David Tellez, et al.. (2019). Deep learning and manual assessment show that the absolute mitotic count does not contain prognostic information in triple negative breast cancer. Cellular Oncology. 42(4). 555–569. 17 indexed citations
6.
Clahsen, P C, et al.. (2011). [Eosinophilic colitis caused by clozapine].. PubMed. 155(36). A3620–A3620. 3 indexed citations
7.
Hage, Jos A. van der, Lambert J. C. M. Van den Broek, Catherine Legrand, et al.. (2004). Overexpression of P70 S6 kinase protein is associated with increased risk of locoregional recurrence in node-negative premenopausal early breast cancer patients. British Journal of Cancer. 90(8). 1543–1550. 76 indexed citations
8.
Denoux, Yves, Paulette Herlin, Marc J. van de Vijver, et al.. (2000). Prognostic value of DNA cytometry in 281 premenopausal patients with lymph node negative breast carcinoma randomized in a control trial. Cancer. 89(8). 1748–1757. 31 indexed citations
9.
Clahsen, P C, C.J.H. Van de Velde, Christian Duval, et al.. (1999). The utility of mitotic index, oestrogen receptor and Ki-67 measurements in the creation of novel prognostic indices fornode-negative breast cancer. European Journal of Surgical Oncology. 25(4). 356–363. 78 indexed citations
10.
Clahsen, P C, C J van de Velde, Christian Duval, et al.. (1998). p53 protein accumulation and response to adjuvant chemotherapy in premenopausal women with node-negative early breast cancer.. Journal of Clinical Oncology. 16(2). 470–479. 144 indexed citations
11.
Clahsen, P C, C J van de Velde, Aron Goldhirsch, et al.. (1997). Overview of randomized perioperative polychemotherapy trials in women with early-stage breast cancer.. Journal of Clinical Oncology. 15(7). 2526–2535. 26 indexed citations
12.
13.
Clahsen, P C, Jan Hein van Dierendonck, Christian Duval, et al.. (1996). Expression of Bcl-2 in node-negative breast cancer is associated with various prognostic factors, but does not predict response to one course of perioperative chemotherapy. British Journal of Cancer. 74(1). 78–85. 104 indexed citations
14.
Clahsen, P C, Jan Hein van Dierendonck, C. Pallud, et al.. (1996). PP-1-6 Expression of BCL-2 in node-negative breast cancer is associated with various prognostic factors, but does not predict response to peri-operative chemotherapy. European Journal of Cancer. 32. 11–11. 1 indexed citations
15.
Vijver, Marc J. van de, Natalja T. ter Haar, Wiljo J. F. de Leeuw, et al.. (1996). SY-1-4 P53 mutations and other genetic changes in invasive and intraductal breast cancer. European Journal of Cancer. 32. 7–7. 2 indexed citations
17.
Clahsen, P C, C J van de Velde, Jean‐Pierre Julien, J.-L. Floiras, & F Mignolet. (1994). Thromboembolic complications after perioperative chemotherapy in women with early breast cancer: a European Organization for Research and Treatment of Cancer Breast Cancer Cooperative Group study.. Journal of Clinical Oncology. 12(6). 1266–1271. 100 indexed citations
18.
Clahsen, P C, et al.. (1993). Perioperative adjuvant chemotherapy in early breast cancer patients, EORTC study 10854. Breast Cancer Research and Treatment. 27. 132. 1 indexed citations
19.
Clahsen, P C, et al.. (1993). Peri-operative adjuvant chemotherapy in breast cancer. The Breast. 2(3). 194–194. 1 indexed citations
20.
Clahsen, P C, et al.. (1992). Recycling of Glutathione during Oxidative Stress in Erythrocytes of the Newborn. Pediatric Research. 32(4). 399–402. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026